Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...
Please provide your email address to receive an email when new articles are posted on . A combination of ipilimumab and nivolumab improved PFS by 37% compared with ipilimumab alone. Researchers also ...
Please provide your email address to receive an email when new articles are posted on . Datopotamab deruxtecan prolonged PFS by 2 months vs. chemotherapy. Fewer grade 3 or higher adverse events ...
CHICAGO -- Five-year results from a phase III trial had experts gushing over lorlatinib's (Lorbrena) progression-free survival (PFS) benefit in ALK-positive non-small cell lung cancer (NSCLC). In the ...
Metformin use in mCRC patients improved PFS during first-line 5-fluorouracil-based chemotherapy, but no OS benefit was observed. The study suggests metformin's potential as an adjunct therapy in mCRC, ...
Molecular risk score plus extent of surgical resection predicted outcomes in grade 1 meningiomas, a new analysis found. Postoperative radiotherapy also improved local tumor control in recurrent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback